Close Menu
USA Biz News Stay Current on Economy News
  • Home
  • USA
  • World
  • Politics
  • Business
    • CEO
    • Realtor
    • Entrepreneur
    • Journalist
  • Sports
    • Athlete
    • Coach
    • Fitness trainer
  • Health
    • Doctor
    • Plastic Surgeon
    • Beauty Cosmetics
  • Economy
  • Life Style
Trending
  • Mr. Eric Y.S.: Anchoring Truth, Purpose, and Impact Through Storytelling
  • From Quiet Beginnings to Purpose-Driven Impact: The Inspiring Journey of Sarah Grace
  • The Journey of Danny B Musique: A Symphony of Passion, Perseverance, and Purpose
  • Novartis Gets Ready for Possible Trump Tariffs: A Pharma Giant on Alert.
  • The U.S. government is thinking about making a website, maybe even with Trump’s name on it, to help people find cheaper medicine.
  • Stocks Pop After Interest Rate Decrease: Great or Just for Wall Street?
  • Trump’s Policies Put Clean Energy Jobs in Danger.
  • Is America Headed Back to a McCarthy Era?   
USA Biz News Stay Current on Economy News
Saturday, March 14
  • Home
  • USA
  • World
  • Politics
  • Business
    • CEO
    • Realtor
    • Entrepreneur
    • Journalist
  • Sports
    • Athlete
    • Coach
    • Fitness trainer
  • Health
    • Doctor
    • Plastic Surgeon
    • Beauty Cosmetics
  • Economy
  • Life Style
USA Biz News Stay Current on Economy News
Home » News » After Wipro, Infosys gets target price cuts post weak Q4 earnings

After Wipro, Infosys gets target price cuts post weak Q4 earnings

Jessica BrownBy Jessica Brown Business
Share
Facebook Twitter LinkedIn Pinterest Email

Infosys Ltd.

Infosys Ltd. | Photo credit: Hollie Adams

After Wipro, the stockbrokers have reduced the prices target information in the midst of the upper line failure and global uncertainties. Infosys on Thursday reported a 11.7 percent decrease in the net consolidated benefit of the fourth quarter to ₹ 7,033 million rupees. You also reduced its income guide to FY26 to 0–3 percent in terms of constant currency (CC).

The institutional actions of Nuvama expect the demand environment to remain challenging for a couple of quarters due to the macro uncertainty. However, the company has not yet seen any change in the terms of execution of agreements.

Meanwhile, Elaara Capital has improved the actions of the reduction to accumulation, citing the visit of at least low Dighth in this uncertain environment.

Nuvama added that the results of the weak Q4 were driven by the lower income of third parties. The brokerage has maintained the purchase rating in Information and at a slower objective price of ₹ 1,700 of ₹ 1,870 before, almost 20 percent of upward potential of the previous closure.

The great technology announced the results of the results after the market on Thursday. The action closed to ₹ 1,420.20 (+0.51 percent) in the EEB.

Return in the head incoming

Nuvama has cut EPS estimates of fiscal year 26 at 3.7 percent, and EPS estimates of fiscal year 27 at 4.6 percent, in the revenue failure of the fourth quarter.

However, brokerage is positive in the sector from a middle -to -lung perspective, since technological debt remains very high for companies, which will guarantee revival in spending as the macro improves.

His Fy26 guide suggests winds against the short term, Elara analysts observed. According to them, the income growth guide or 0-3 percent for fiscal year 26 seems realistic, considering uncertainty in the short term due to the interruption related to the rate.

Analysts have taken into account the growth of income of 1.3 percent in estimates of the fiscal year 26 (0.7 percent organic) followed by a 4 percent growth in fiscal year 2017, since Infosys is likely to be a beneficiary when discretionary expenses spend.

“The growth is likely to be withdrawn in the fiscal year27. We are not building in any expansion of the material margin, since the guide of the margin band without changes for the fiscal year 2016 suggests limited margin levers in our opinion,” they added.

Elara has reduced profing estimates of fiscal year 26-27 by 6-8 percent and reduced the target price to ₹ 1,530 from ₹ 1,830 before.

Emkay Global has maintained the purchase at the revised target price of ₹ 1,650.

Posted on April 18, 2025

Previous ArticleAt least two killed in Russian attacks on Ukraine’s Kharkiv, Sumy | Russia-Ukraine war News
Next Article Trump says China calling ‘a lot,’ deal could be reached in as soon as three weeks

Keep Reading

Novartis Gets Ready for Possible Trump Tariffs: A Pharma Giant on Alert.

Trump’s Policies Put Clean Energy Jobs in Danger.

Argentina’s Soy Industry: Caught in the Crossfire of U.S.-China Trade Tensions.

Should Companies Ditch Quarterly Earnings Reports? Trump Thinks So.

People in the U.S. Are Feeling Less Hopeful in September: What It Means.

The Treasury Secretary Warns: Canceling Tariffs Could Be Really Expensive.

Most View

Novartis Gets Ready for Possible Trump Tariffs: A Pharma Giant on Alert.

September 20, 2025

Trump’s Policies Put Clean Energy Jobs in Danger.

September 19, 2025

Argentina’s Soy Industry: Caught in the Crossfire of U.S.-China Trade Tensions.

September 18, 2025
Latest Posts

Novartis Gets Ready for Possible Trump Tariffs: A Pharma Giant on Alert.

September 20, 2025

Trump’s Policies Put Clean Energy Jobs in Danger.

September 19, 2025

Argentina’s Soy Industry: Caught in the Crossfire of U.S.-China Trade Tensions.

September 18, 2025

Should Companies Ditch Quarterly Earnings Reports? Trump Thinks So.

September 16, 2025

USA

  • World
  • Politics
  • Economy
  • Life Style

Business

  • CEO
  • Realtor
  • Entrepreneur
  • journalist

Sports

  • Athlete
  • Coach
  • Fitness Trainer

Health

  • Doctor
  • Plastic Surgeon
  • Beauty Cosmetics
© 2017-2026 usabiznews. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.